Pharma Journalist -

Gotham Therapeutics, a biotechnology company developing a novel drug class targeting RNA-modifying proteins, and ZoBio, the leading contract research organization in integrated…
Read More...

Merck, known as MSD outside the United States and Canada, and Peloton Therapeutics, Inc. announced that the companies have entered into a definitive agreement under which Merck, through…
Read More...

SMi Reports: Registration is open for SMi Group’s inaugural Wearable Injectors and Connected Devices Conference taking place in October. SMi are proud to present the inaugural…
Read More...

SGS celebrated the official opening of the Biologics, Viral Vaccine, Gene and Cell Therapy Testing facility expansion in Glasgow, UK earlier this month (Thursday May 9, 2019). The…
Read More...

In an oral presentation from the Digestive Disease Week medical conference in San Diego, California today, Eli Lilly and Company announced new safety and efficacy data for mirikizumab…
Read More...

WuXi Biologics announced that it has entered into a strategic partnership Letter of Intent (LOI) with a global vaccine leader, pursuant to which WuXi Vaccines will build a dedicated…
Read More...

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with the Alliance for Clinical Trials…
Read More...

Catalent, Inc. announced that it has completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene…
Read More...

Evotec SE announced the signing of a definitive agreement under which Evotec will acquire Just Biotherapeutics, Inc. (“Just.Bio”), for up to $ 90 m including potential performance-based…
Read More...

New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential…
Read More...